Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,180 | 12,210 | 18,270 | 8,750 | 14,680 |
| Marketable Securities | 12,620 | 14,470 | 15,300 | 2,330 | 3,590 |
| Other current assets | 700 | 850 | 510 | 1,040 | 740 |
| TOTAL | $21,500 | $27,530 | $34,080 | $12,120 | $19,010 |
| Non-Current Assets | |||||
| PPE Net | 1,500 | 1,470 | 1,450 | 1,410 | 1,390 |
| Other Non-Current Assets | 700 | 710 | 740 | 780 | 800 |
| TOTAL | $2,200 | $2,180 | $2,190 | $2,190 | $2,190 |
| Total Assets | $22,440 | $28,430 | $35,030 | $13,110 | $20,020 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,150 | 2,020 | 1,740 | 960 | 1,710 |
| Accrued Expenses | 5,380 | 3,480 | 4,020 | 5,050 | 4,330 |
| TOTAL | $7,540 | $5,500 | $5,760 | $6,020 | $6,050 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 260 | 520 | 520 | 70 | 70 |
| TOTAL | $260 | $520 | $520 | $70 | $70 |
| Total Liabilities | $7,810 | $6,030 | $6,290 | $6,090 | $6,130 |
| Shareholders' Equity | |||||
| Common Shares | 460 | 460 | 460 | 290 | 290 |
| Retained earnings | -170,020 | -164,750 | -159,200 | -157,400 | -150,290 |
| Other shareholders' equity | 5,720 | 8,350 | 9,320 | -210 | 0 |
| TOTAL | $14,630 | $22,400 | $28,730 | $7,010 | $13,890 |
| Total Liabilities And Equity | $22,440 | $28,430 | $35,020 | $13,100 | $20,020 |